| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.960 | 99 | 35 | 1990 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.985 | 68 | 7 | 1990 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0.977 | 44 | 1 | 1994 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 41 | 0 | 1985 | 2019 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
disease | 0.100 | None | 1.000 | 38 | 0 | 2016 | 2019 | ||||||||
|
gastrin releasing peptide | 0.524 | 0.769 | 2.5E-03 |
|
disease | 0.100 | None | 1.000 | 36 | 0 | 1986 | 2019 | ||||||||
|
achaete-scute family bHLH transcription factor 1 | 0.552 | 0.692 | 0.68 |
|
disease | 0.400 | None | 1.000 | 36 | 0 | 1997 | 2020 | ||||||||
|
enolase 2 | 0.475 | 0.846 | 0.38 |
|
disease | 0.100 | None | 1.000 | 31 | 0 | 1987 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.400 | None | 0.857 | 28 | 2 | 1991 | 2018 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.100 | None | 0.958 | 24 | 0 | 1991 | 2019 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.100 | None | 1.000 | 23 | 0 | 1989 | 2019 | ||||||||
|
delta like canonical Notch ligand 3 | 0.552 | 0.654 | 5.4E-05 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 2017 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 0.905 | 21 | 2 | 1989 | 2012 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
disease | 0.100 | None | 1.000 | 19 | 0 | 2012 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.200 | None | 1.000 | 19 | 5 | 2002 | 2018 | ||||||||
|
small cell cancer of the lung | 0.612 | 0.577 |
|
disease | 0.100 | None | 0.944 | 18 | 0 | 1987 | 2019 | |||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
disease | 0.100 | None | 0.941 | 17 | 0 | 1985 | 2019 | ||||||||
|
MYCL proto-oncogene, bHLH transcription factor | 0.599 | 0.731 | 0.12 |
|
disease | 0.400 | None | 1.000 | 17 | 0 | 1987 | 2017 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.100 | None | 1.000 | 16 | 3 | 2002 | 2018 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.938 | 16 | 0 | 2008 | 2019 | ||||||||
|
NK2 homeobox 1 | 0.457 | 0.808 | 0.36 |
|
disease | 0.100 | None | 0.938 | 16 | 0 | 2003 | 2020 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.450 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 16 | 0 | 2008 | 2019 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1995 | 2019 | ||||||||
|
collagen type XI alpha 2 chain | 0.435 | 0.846 | 0.70 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 2017 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.100 | None | 0.923 | 13 | 0 | 1989 | 2017 |